by reason for retraction – Retraction Watch

Former Mount Sinai postdoc falsified images in grant updates, ORI says

The U.S. Office of Research Integrity has sanctioned a former postdoctoral fellow at the Icahn School of Medicine at Mount Sinai in New York for manipulating images in two grant updates and a manuscript.

Chen-Yeh “George” Ke committed research misconduct by intentionally falsifying images in an unpublished manuscript supported by federal funds and by reporting the fabricated results in two research performance progress reports, according to a summary published March 10 on the ORI website and to be published in the Federal Register.

Ke, now a manager at Level Biotechnology in Taiwan, according to LinkedIn, did not return messages seeking comment. A spokesperson from Mount Sinai acknowledged our message but did not comment before our deadline.

Stolen economics study retracted following Retraction Watch coverage

An economics study that was stolen and had its authorship slots sold by a paper mill has been retracted.

The move follows our reporting in January about a researcher in India who took to social media after an academic journal rejected her paper, noting that it had high similarity to a study published by other authors — despite the work being her own.

Vijayalakshmi S, an economics researcher at RV University in Bengaluru, had presented the study at a conference, and had a previous version rejected from a different journal. S concluded her paper was somehow stolen during either of those instances. Another researcher told us at the time that a post he found on Telegram offered authorship slots on S’s study for less than $200 apiece.

Publisher demands $500 from impersonated author to retract paper

Last year, we wrote about a Walsh Medical Media journal that refused to withdraw an author’s paper unless he paid a fee — even though he didn’t write or submit the article. For one reader, some details of that story were familiar.

Laertis Ikonomou, an associate professor at the University at Buffalo in New York, discovered last September he was listed as an author on a commentary he had never seen before that had been published in the Journal of Carcinogenesis & Mutagenesis. He immediately requested the journal remove the article, and, like our previous story, the journal demanded a fee to do so. But after a few exchanges, the journal just changed the author on the paper to a different name.

The Journal of Carcinogenesis & Mutagenesis is one of 77 published by Walsh Medical Media. The publisher calls itself a “global leader” in open access publishing and, although it bills itself as a healthcare publishing company, has journals with specialties ranging from chemical engineering, coastal zone management, and intellectual property rights, as we have previously reported.

A medical journal says the case reports it has published for 25 years are, in fact, fiction

A Canadian journal has issued corrections on 138 case reports it published over the last 25 years to add a disclaimer: The cases described are fictional.

Paediatrics & Child Health, the journal of the Canadian Paediatric Society, has published the cases since 2000 in articles for a series for its Canadian Paediatric Surveillance Program. The articles usually start with a case description followed by “learning points” that include statistics, clinical observations and data from CPSP. The peer-reviewed articles don’t state anywhere the cases described are fictional.

The corrections come following a January article in New Yorker magazine that mentioned one of the reports — “Baby boy blue,” a case published in 2010 describing an infant who showed signs of opioid exposure via breast milk while his mother was taking acetaminophen with codeine. The New Yorker article made public an admission by one of the coauthors that the case was made up.

Researcher ‘honestly shocked’ to discover name on paper, editor claims misunderstanding

While reviewing her Google Scholar profile to prepare a list of her publications, psychologist Maryam Farhang came across a paper she didn’t recognize.

The article, in the Journal of Research in Allied Life Sciences, included her name and affiliation, but Farhang hadn’t written or contributed to the paper in any way, she told Retraction Watch.

“I was honestly shocked and very concerned to see my name and affiliation used without my permission,” said Farhang, an associate research professor at Universidad de Las Américas in Chile. “This is not only unethical, but a serious breach of research integrity. As a researcher, authorship comes with responsibility, seeing my name attached to work that I neither wrote nor approved was professionally alarming and personally upsetting.”

Heart researcher asked to attend remedial training after OSU misconduct finding, report reveals

In a move one research ethics expert called “odd,” a university asked one of its professors to attend a remedial integrity course — despite their “significant concerns” the training would have any impact following findings of misconduct.

In 2024, Retraction Watch covered the case of Govindasamy Ilangovan, then an associate professor of cardiovascular medicine at The Ohio State University. We reported at that time two of his papers were retracted from Heart and Circulatory Physiology at the request of the university, and that university officials had requested a third retraction. Thanks to a public records request, we now have access to the university’s 2023 final investigation report, which provides us much more information.

The released material shows a committee of the university’s research integrity officers found Ilangovan responsible for manipulating images in three papers. OSU redacted the total number of images in question, but the investigators deemed it “very concerning.”

Porn addiction recovery group sues publisher, UCLA researcher over critical paper

An online peer support group for people overcoming addiction to pornography has filed a lawsuit against the authors of a paper critical of the group, as well as the publisher Taylor & Francis, in an attempt to get the article retracted.

The 2023 study, published in Deviant Behavior, found the Reddit channel for the group NoFap had a higher rate of posts containing violent language compared with two similar subreddits.

Study coauthors Nicole Prause, a bioinformatics programmer with the University of California, Los Angeles, and clinical psychologist David Ley are named defendants in the lawsuit, filed December 30. NoFap and the group’s founder, Alexander Rhodes, are plaintiffs in the suit, which alleges the authors manipulated the data to make the subreddit seem uniquely violent.

Gynecologists in Italy collect more retractions and an expression of concern

A group of gynecologists in Italy has tallied yet another retraction, this time for an article with “significant overlap” with the methods, data and text of an older paper that shares two of the same authors.

The paper, which involved research on a treatment for infertility, is the latest in a string of retractions for Sandro Gerli and Gian Carlo Di Renzo of the University of Perugia, and Vittorio Unfer, now at Saint Camillus International University of Health Sciences in Rome. Just a few weeks earlier, the researchers also received an expression of concern on a separate paper examining a widely used supplement for polycystic ovary syndrome.

Commenters on PubPeer began to flag the researchers’ papers two years ago, and they now have 11 retractions among them, largely for duplicated data and text across the publications, as well as undisclosed conflicts of interest and unreliable study methods. In 2024, Di Renzo threatened legal action over a critic’s allegations about data duplications among several papers he coauthored — many of which have since been retracted.

Nature journal retracts two papers by immunology researchers for image duplication

A Nature journal has retracted a decades-old immunology paper that has been cited more than 1,000 times and, the author claims, spurred the development of new drugs.

The paper on antibody diversity appeared in Nature Immunology in 2002. The article, cited 1,016 times, according to Clarivate’s Web of Science, is the most cited work for corresponding author Andrea Cerutti, a professor at the Catalan Institution for Research and Advanced Studies in Spain.

The retraction comes on the heels of another retraction for Cerrutti, also for a paper in Nature Immunology. Both had been flagged on PubPeer for image issues. The authors maintain there was no misconduct.

Court challenge could chill reporting of research fraud, say whistleblower attorneys

The U.S. government recently announced a record $6.8 billion in False Claims Act settlements and judgments in 2025, the most in a single year since the law’s enactment 163 years ago. For those concerned with scientific integrity, another significant FCA record was also set in 2025: the number of suits brought under the FCA by private individuals against entities they believe defrauded the federal government.

Successful qui tam suits brought under the FCA can come with incentivizing monetary rewards – sometimes substantial – for the whistleblowers. Whistleblowers filed a record 1,297 of these so-called qui tam lawsuits in 2025, up from 979 suits in 2024.

Despite the FCA’s banner year, legal experts say a pending challenge may weaken the law’s whistleblower power and impact. A Florida district court recently struck down the FCA’s qui tam provisions as unconstitutional because these suits involve individuals suing on behalf of the government. If an appeals court upholds the decision, some whistleblowers in that court’s jurisdiction may no longer get paid for exposing wrongdoing, a change that could allow more fraud to slip under the radar, legal analysts say.

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: